title: [CME. Severe cutaneous drug reaction].
authors.affiliation: Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Deuel
authors.affiliation: Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
authors.forename: Dominik
authors.initials: D
authors.lastname: Schaer
authors.affiliation: Klinik für Dermatologie, Allergiestation, Universitätsspital Zürich.
authors.forename: Peter
authors.initials: P
authors.lastname: Schmid-Grendelmeier
authors.affiliation: Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich.
authors.forename: Florence
authors.initials: F
authors.lastname: Vallelian
mesh_terms: D056150:Acute Generalized Exanthematous Pustulosis / Q000175:diagnosis / Q000628:therapy; D000368:Aged; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D003875:Drug Eruptions / Q000175:diagnosis* / Q000628:therapy; D063926:Drug Hypersensitivity Syndrome / Q000175:diagnosis / Q000628:therapy; D004347:Drug Interactions; D004802:Eosinophilia / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D055553:Prescription Drugs / Q000009:adverse effects; D011379:Prognosis; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis / Q000628:therapy; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D055553:Prescription Drugs; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D008775:Methylprednisolone